Key Takeaways Doximity shares jumped Friday morning after the digital medical networking company topped quarterly earnings forecasts, provided a better-than-expected current-quarter outlook, and unveiled a stock buyback program. Subscription revenue in the fiscal fourth quarter was $112.7 million, a 9% increase from a year earlier, helping to boost top-line growth. Monitor the $28 level, an area where the stock may find overhead resistance from a horizontal line connecting a series of price action over the ...

Investors found a lot to like about the healthcare technology company's latest quarterly update. Shares of Doximity (DOCS 16.60%) were skyrocketing 15.9% higher as of 10:54 a.m. ET on Friday. The big gain came after the healthcare technology company announced its fiscal 2024 fourth-quarter and full-year results following market close on Thursday. Doximity reported fiscal Q4 revenue of $118.1 million, a 6% year-over-year increase. This topped the consensus revenue estimate of roughly $116.5 million. The comp ...

Doximity, Inc. (NYSE:DOCS) Q4 2024 Earnings Conference Call May 16, 2024 5:00 PM ET Company Participants Perry Gold - Vice President Investor Relations Jeff Tangney - Co-Founder and Chief Executive Officer Anna Bryson - Chief Financial Officer Nate Gross - Co-Founder and Chief Strategy Officer Conference Call Participants Brian Peterson - Raymond James Scott Berg - Needham & Company Jared Hass - William Blair Richard Close - Canaccord Genuity Glen Santangelo - Jefferies Elizabeth Anderson - Evercore ISI Dan ...

Doximity (DOCS) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.20 per share a year ago. These figures are adjusted for non- recurring items. This quarterly report represents an earnings surprise of 25%. A quarter ago, it was expected that this medical social networking site would post earnings of $0.24 per share when it actually produced earnings of $0.29, delivering a surprise of 20.83%. Over the last four quarte ...

Class Period: February 9, 2022 – April 1, 2024 Lead Plaintiff Deadline: June 17, 2024 LOS ANGELES, May 16, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Doximity, Inc. ("Doximity" or the "Company") (NYSE: DOCS). To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the ...

The Doximity class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that defendants repeatedly touted Doximity's business prospects and the sustainability of Doximity's revenue growth and profitability, while downplaying the impact of competition and tightening macroeconomic conditions on Doximity as well as its reliance on "upselling" products and services (such as additional advertising) to existing customers to sustain Do ...

Core Viewpoint - A securities fraud class action lawsuit has been filed against Doximity, Inc. by Kessler Topaz Meltzer & Check, LLP on behalf of investors who purchased Doximity common stock between February 9, 2022, and April 1, 2024, due to alleged misleading statements regarding the company's financial health and growth prospects [1][3]. Group 1: Company Background and Allegations - Doximity operates a digital platform that connects medical professionals and provides medical information and patient scheduling tools [3]. - The lawsuit claims that during the Class Period, Doximity's executives made repeated assurances about the sustainability of the company's growth and profitability while downplaying the significance of customer upsell rates [3][4]. - On August 8, 2023, Doximity reported better-than-expected quarterly revenue but provided disappointing guidance for the second quarter and the full fiscal year 2024, leading to a workforce reduction of approximately 10% [3][4]. Group 2: Financial Impact and Stock Performance - Following the August 8, 2023 announcement, Doximity's stock price fell by $7.49 per share, nearly 23%, from $32.79 to $25.30 [4]. - On April 1, 2024, a report from Jehoshaphat Research indicated that Doximity's underlying sales were declining at a rate of -3% to -6%, which was previously obscured by accelerated revenue recognition [5]. - This revelation caused Doximity's stock to decline by $1.11 per share, over two trading days, from $26.91 to $25.80 [5].

In its upcoming report, Doximity (DOCS) is predicted by Wall Street analysts to post quarterly earnings of $0.20 per share, reflecting no change compared to the same period last year. Revenues are forecasted to be $116.46 million, representing a year-over-year increase of 5%.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Before a company anno ...

The three-year-long historic public health crisis significantly altered the structure and trend of the Medical Services sector. The growing demand for remote treatment led to a tremendous upsurge in digital healthcare options. Even after the pandemic, demand for digital healthcare treatment has continued to grow in the form of telemedicine-focused online medical and AI-powered technology services, backed by the adoption of data and analytics.According to a recent Precedence Research report, the global healt ...

Investors interested in stocks from the Medical Services sector have probably already heard of Surgery Partners (SGRY) and Doximity (DOCS) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our Style Scores hi ...